CHRONIC KIDNEY DISEASE DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Chronic Kidney Disease Drugs Market, By Drug Class (ACE Inhibitors, Angiotensin Receptor Blockers (ARBs), B-Blockers, Calcium Channel Blockers, Loop Diuretics, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Others), By Route of Administration (Oral and Parentral), By Indication (Diabetic Nephropathy, Glomerulonephritis, Hypertensive Nephropathy, Polycystic Kidney Disease, Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies , Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In: 03 Apr, 2026
Code: CMI1713
Page number: 206
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Chronic Kidney Disease Drugs Market, By Drug Class
  - Global Chronic Kidney Disease Drugs Market, By Route of Administration
  - Global Chronic Kidney Disease Drugs Market, By Indication
  - Global Chronic Kidney Disease Drugs Market, By Distribution Channel
  - Global Chronic Kidney Disease Drugs Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
Global Chronic Kidney Disease Drugs Market, By Drug Class, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- ACE Inhibitors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Angiotensin Receptor Blockers (ARBs)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- B-Blockers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Calcium Channel Blockers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Loop Diuretics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Erythropoiesis-Stimulating Agents (ESAs)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Phosphate Binders
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Chronic Kidney Disease Drugs Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Parentral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Chronic Kidney Disease Drugs Market, By Indication, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Diabetic Nephropathy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Glomerulonephritis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hypertensive Nephropathy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Polycystic Kidney Disease
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Indications
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Chronic Kidney Disease Drugs Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Global Chronic Kidney Disease Drugs Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
  - Market Y-o-Y Growth Analysis (%), 2021 - 2033, (USD Bn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, V (USD Bn)
  - Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, V (USD Bn)
  - Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, V (USD Bn)
  - Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, V (USD Bn)
  - Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, V (USD Bn)
  - Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Drug Class, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, V (USD Bn)
  - Market Size and Forecast, By Indication, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Amgen Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- F. Hoffmann-La Roche Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pfizer, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- GlaxoSmithKline plc (GSK)
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Keryx Biopharmaceuticals, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Kissei Pharmaceutical Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Regeneron Pharmaceuticals, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Reata Pharmaceuticals, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Ardelyx, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Boehringer Ingelheim International GmbH
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novo Nordisk A/S
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Johnson & Johnson
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Astellas Pharma Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Takeda Pharmaceutical Company Limited
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Akebia Therapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on ' Chronic Kidney Disease Drugs Market' - Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now